Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spero R Cataland

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2014
Eculizumab therapySpero R Cataland
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Recent advances in the management of atypical hemolytic uremic syndromeSpero R Cataland
Blood|August 20, 2011
3 Rs: rituximab, remission, relapseSpero R Cataland
Blood|June 20, 2024
Relapse and iTTP: beyond the ADAMTS13 activitySpero R Cataland
Clinical Advances in Hematology & Oncology : H&O|November 7, 2024
Recombinant ADAMTS13 concentrate in thrombotic thrombocytopenic purpuraSpero R Cataland
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Novel therapies in thrombotic thrombocytopenic purpuraCamila Masias, Spero R Cataland
Blood|November 13, 2025
Rewriting the natural history of cTTPSenthil Sukumar, Spero R Cataland
Annals of Hematology|November 17, 2012
Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutationRyan Carr, Spero R Cataland
Blood|July 15, 2018
The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosisCamila Masias, Spero R Cataland
Seminars in Hematology|October 18, 2011
Practical issues in ADAMTS13 testing and emerging therapies in thrombotic thrombocytopenic purpuraSpero R Cataland, Haifeng M Wu
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2014
Eculizumab therapySpero R Cataland
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Recent advances in the management of atypical hemolytic uremic syndromeSpero R Cataland
Blood|August 20, 2011
3 Rs: rituximab, remission, relapseSpero R Cataland
Blood|June 20, 2024
Relapse and iTTP: beyond the ADAMTS13 activitySpero R Cataland
Clinical Advances in Hematology & Oncology : H&O|November 7, 2024
Recombinant ADAMTS13 concentrate in thrombotic thrombocytopenic purpuraSpero R Cataland
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Novel therapies in thrombotic thrombocytopenic purpuraCamila Masias, Spero R Cataland
Blood|November 13, 2025
Rewriting the natural history of cTTPSenthil Sukumar, Spero R Cataland
Annals of Hematology|November 17, 2012
Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutationRyan Carr, Spero R Cataland
Blood|July 15, 2018
The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosisCamila Masias, Spero R Cataland
Seminars in Hematology|October 18, 2011
Practical issues in ADAMTS13 testing and emerging therapies in thrombotic thrombocytopenic purpuraSpero R Cataland, Haifeng M Wu
Pageof 9